Sangamo Therapeutics (SGMOQ) Cash & Equivalents Growth (3y) (2013 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Cash & Equivalents Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 15.74% |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | -21.61% |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | -20.41% |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -12.18% |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 42.85% |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -40.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -40.70% |
| Sep 30, 2025 | -32.09% |
| Jun 30, 2025 | -31.19% |
| Mar 31, 2025 | -40.60% |
| Dec 31, 2024 | -38.35% |
| Sep 30, 2024 | -39.49% |
| Jun 30, 2024 | -45.31% |
| Mar 31, 2024 | -23.80% |
| Dec 31, 2023 | -29.92% |
| Sep 30, 2023 | -39.83% |
| Jun 30, 2023 | -47.71% |
| Mar 31, 2023 | -3.01% |
| Dec 31, 2022 | 7.69% |
| Sep 30, 2022 | -6.12% |
| Jun 30, 2022 | -11.40% |
| Mar 31, 2022 | 14.09% |
| Dec 31, 2021 | 8.40% |
| Sep 30, 2021 | 65.13% |
| Jun 30, 2021 | 41.94% |
| Mar 31, 2021 | 58.80% |